FDA Adverse Event Malfunction Summary report: N

ELECSYS CMV IGG

MDR report key: 14694060 · Received June 15, 2022

Report

Report Number
1823260-2022-01738
Event Type
Malfunction
Date Received
June 15, 2022
Date of Event
May 18, 2022
Report Date
August 19, 2022
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LFZ
UDI-DI
04015630940172
PMA / PMN Number
K131605
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

SAMPLES FROM THE PATIENT WERE PROVIDED FOR INVESTIGATION AND THE RESULTS OBTAINED BY THE CUSTOMER COULD BE REPRODUCED.

Additional Manufacturer Narrative · 0

FOR CALIBRATIONS PERFORMED ON (B)(6)2022 AND (B)(6)2022, SIGNALS WERE WITHIN EXPECTED RANGES. ON (B)(6)2022, CONTROLS RECOVERED WITHIN SPECIFIED RANGES. FURTHER INVESTIGATIONS OF THE PATIENT SAMPLE DETERMINED IT TO BE CORRECTLY NON-REACTIVE WITH THE ELECSYS CMV IGG ASSAY. THE NON-REACTIVE ELECSYS CMV IGG RESULT WAS SUPPORTED BY MIKROGEN RECOMLINE BLOT RESULTS, WHICH WERE NEGATIVE FOR CMV IGG AND REACTIVE FOR CMV IGM. FURTHER INVESTIGATION INDICATED THAT A PRIMARY INFECTION WAS UNLIKELY DUE TO THE CONSTANT IGM RESPONSE AND THE ABSENCE OF A SEROCONVERSION.

Description of Event or Problem · 0

THE INITIAL REPORTER STATED THEY RECEIVED DISCREPANT RESULTS FOR ONE PATIENT SAMPLE TESTED WITH THE ELECSYS CMV IGG ASSAY ON A COBAS 8000 E 801 MODULE (SERIAL NUMBER (B)(4)). THE SAMPLE RESULTED IN A CMV IGG VALUE OF 0.31 U/ML (NON-REACTIVE) WHEN TESTED ON THE E 801 ANALYZER. THE VALUE FROM THE E 801 ANALYZER WAS REPORTED OUTSIDE OF THE LABORATORY. AN ALIQUOT OF THIS SAMPLE WAS SENT TO ANOTHER LABORATORY FOR TESTING USING THE DIASORIN LIAISON XL METHOD, RESULTING IN A VALUE OF 104 U/ML (IMMUNE/REACTIVE).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2807526 ELECSYS CMV IGG ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS LFZ ROCHE DIAGNOSTICS NA 59618801 04015630940172

Patients

Seq Age Sex Outcome Treatment
1 26 YR Female